Stock NNVC NANOVIRICIDES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus NanoViricides, Inc.

Equities

NNVC

US6300873022

Delayed Nyse
Other stock markets
 13:10:00 2024-07-03 EDT 		5-day change 1st Jan Change
1.76 USD -1.12% Intraday chart for NanoViricides, Inc. -3.30% +72.55%
07-01 NanoViricides, Inc. Announces Clinical and Pre-Clinical Pipeline and Unique Host-Mimetic, Virusilling, Technology Platform Intending to Revolutionize Treatment of Viral Infections CI
06-20 Nanoviricides, Inc. Reports Nv-387 Is Effective in Protecting Lungs from Damage in Lethally Infected Animal Model CI

Evolution of the average Target Price on NanoViricides, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c02176fe2a.SS8kafbuN5ySwGaO_5C1licJ6_FePWDcMlZEcueYpuo.HG5KP4Ctetbmgw-4ldiBxnNtqJtnajGKBTE2Hqj81pw5VW8aoNkF8cT0DQ~08e4e185b91bb30ab3dca630fcb9f5d2

Analyst Recommendations on NanoViricides, Inc.

EF Hutton Lowers Price Target on NanoViricides to $5.25 From $8.50, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.76 USD
Average target price
6.5 USD
Spread / Average Target
+269.32%
High Price Target
6.5 USD
Spread / Highest target
+269.32%
Low Price Target
6.5 USD
Spread / Lowest Target
+269.32%

Consensus detail

Consensus revision (last 18 months)

Analysts covering NanoViricides, Inc.

EF Hutton

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NNVC Stock
  4. Consensus NanoViricides, Inc.